CompoAtlas

Puravita Magnesium L-threonate

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Magnésium

Source : L-thréonate de magnésium

50 mg150,000 µg

Non-medicinal ingredients

Cellulose microcristalline, Hypromellose, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adolescents et adultesminimum: 9 years ; maximum: 18 years1 Capsuleminimum: 1 Tous les jours ; maximum: 3 Tous les jours
Adultesminimum: 19 years1 Capsuleminimum: 1 Tous les jours ; maximum: 3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in normal growth and development. A factor in the maintenance of good health. Helps in bone development. Helps in energy metabolism/(and) tissue formation. Helps in the development and maintenance of bones/(and) teeth. Helps to maintain/support normal electrolyte balance. Helps to maintain/support normal muscle function, including the heart muscle. Helps to maintain/support the body's ability to metabolize nutrients. Source of/Provides (an) electrolyte(s) for the maintenance of good health. Source of/Provides (an) electrolyte(s).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Product record

Other names
Magnesium L-threonate, Puravita Magnesium
Licence holder
Puravita Pharma Ltd.
NPN or DIN-HM
80139420
Status
Active licence
Licence date
21 March 2025
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

Source

Official Health Canada record, licence 80139420

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Puravita Magnesium L-threonate (Puravita Pharma Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80139420-puravita-magnesium-l-threonate, updated 21 March 2025.

Enter to analyse, Shift+Enter for a new line